Page last updated: 2024-09-27
Fetal Pyelectasis
Dilation of fetal KIDNEY PELVIS. It is a common PRENATAL ULTRASONOGRAPHY finding with no significant long-term sequelae.
Synonyms(3)
| Synonym |
|---|
| Pyelectasis |
| Prenatal Fetal Pyelectasis |
| Fetal Pyelectasis |
Research Excerpts
Overview
| Excerpt | Reference |
|---|---|
| "Pyelectasis is a benign condition." | ( García Nieto, V; García Rodríguez, VE; González Cerrato, S; Hernández González, MJ; Luis Yanes, MI; Mesa Medina, O; Monge Zamorano, M, 2011) |
Research
Studies (3)
| Timeframe | Studies, This Condition (%) | All Conditions % |
|---|---|---|
| pre-1990 | 0 (0.00) | 23.3326 |
| 1990's | 0 (0.00) | 12.5806 |
| 2000's | 0 (0.00) | 18.1394 |
| 2010's | 2 (66.67) | 28.8240 |
| 2020's | 1 (33.33) | 9.53 |
Drugs Studied (4)
| Drug | Indicated | Relationship Strength | Studies | Trials |
|---|---|---|---|---|
| cyclohexanol | 0 | low | 1 | 0 |
| venlafaxine hydrochloride | 0 | low | 1 | 0 |
| deamino arginine vasopressin | 0 | low | 1 | 0 |
Protein Targets (18)
| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|---|---|---|---|
| GLI family zinc finger 3 | 2 | 0 | 0 | 2 |
| retinoic acid nuclear receptor alpha variant 1 | 1 | 0 | 0 | 1 |
| retinoid X nuclear receptor alpha | 2 | 0 | 0 | 2 |
| pregnane X nuclear receptor | 2 | 0 | 0 | 2 |
| aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
| geminin | 2 | 0 | 0 | 2 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
| Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | ||||